Event Overview

Cancer incidence rates among the young has increased drastically in the MENA region. An alarming outcome, which indicates the requirement of focused research to address potential risk factors. Although developed MENA countries have shown promising health outcomes, the same cannot be said about developing countries in the region. Overall, Cancer is the third leading cause of death in the region. The MENA Cancer Care Summit, will be an exclusive 2-day event, which will include strategic deliberations on the whole oncology eco system. The event will focus on recent advances, current challenges and emerging therapies in the cancer care spectrum. The event will have an inclusive approach towards understanding the importance of technology & research in early detection, clinical approaches, prevention and control. The MENA Cancer Care Summit, will be a great opportunity for healthcare authorities, healthcare professionals, researchers, academics and cancer control o fficials fro m the region to engage and discuss on mitigating the effects of cancer.

40

Speakers

04

Panel Discussions

25

Sponsors, Partners & Exhibitors

500

Delegates

20

Solution Providers

25

Media Partners

Benefits of attending

Understand effective and targeted therapy models for oncology and their impact

Hear from global experts on methods to diagnose critical care patients and digitization of care delivery

Learn about emerging technologies which will revolutionize cancer detection, treatment & control

Identify regional cancer incidence burden and benchmark infrastructure needs to tackle the problem

Hear from oncology experts from around the world about diagnostic & therapeutic best practices in the cancer care continuum

Network with regional and global thought leaders, scientists, healthcare professionals and authorities

Explore new solutions, technologies and services which will further improve quality of life and cancer treatment protocols

Current Trends

  • Highest Cancer Mortality Rate - An estimated 108 people died from cancer per 100,000 of the population in Egypt last year
  • Saudi Cancer Incidence Rate – 39% among the age group 20 – 49 years
  • UAE Cancer Incidence Rate – 37% among the age group 20 – 49 years
  • GCC estimated Oncology market size to reach $5.1 billion by 2027, growing at a CAGR of 11.2% between 2022-2027
  • Chemotherapy segment is estimated to grow with the fastest CAGR of 12.1% during the forecast period 2022-2027
  • Regional Oncology Information system market estimated to grow at CAGR 7.08% valued at $ 286.42 million by 2027
  • Cancer Immunotherapy market pegged to grow at a CAGR of 11.35% from 2022-2027. Predicted to be worth $9.21 billion by 2027

Key Themes

  • Cancer Genetics & Genomics
  • Cancer Immunotherapy & Vaccines
  • The Future of Cancer Research
  • Cancer Drugs Advancements
  • Oncology Infrastructure
  • Emerging Cancer Detection Trends
  • Epidemiology, Statistics & Health Outcomes
  • Recent Trends in Cancer Therapy
  • Technologies & Innovations in Cancer Care & Treatment

Confirmed Speakers

 


Prof. Dr.samesh Mohamed Abdel Wahab

President

Egyptian Society of Intervention Radiology

 


Dr. Yasser Elborai

Professor of Pediatric Hematology Oncology & Stem Cell Transplant
National Cancer Institute, Cairo University

 


Dr. Sarthak Moharir

Consultant Radiation Oncologist
HCG Cancer Centre

Media Partners

Event Agenda

AGENDA DAY ONE

ScheduleOpening Section+

Schedule

  • Registration & Networking
  • Welcome remarks by the organizer
  • Opening Address: Reimagining Healthcare structures to combat inherent inequalities in cancer care systems
Session 1The Current State of Cancer +

Schedule

  • Strategic Presentation: Developing a robust cancer control infrastructure in the MENA region
  • Presentation: Burden of female breast cancer in the Middle East and North Africa region
  • Expert Panel: Strengthening Cancer research capabilities – Challenges & Opportunities
Session 2 Emerging Technologies in Cancer Care & Treatments+

Schedule

  • Supporting breakthrough innovations in the areas of Oncology & Digital Health
  • Tech presentation: Offering significant and equitable improvements in personalized cancer screening with AI
  • Tech Highlight: Precision Oncology: Innovative Next-Generation Sequencing (NGS)- Optimizing the full cycle of cancer management
  • Expert Panel: Exploring new frontiers for delivering cancer screening & detection
  • Keynote: Researching Evolutionary Changes via Cancer Genetics & Comparative Genomics
  • Interactive Q & A

AGENDA DAY TWO

ScheduleOpening Section+

Schedule

  • Registration & Networking
  • Welcome remarks by the organizer
  • Opening Keynote: Forecasting Oncology research and Therapy advances – 2022 & Beyond
Session 3Cancer Research & Emerging Therapies+

Schedule

  • Impact Topic: COVID 19- Re-emerging from the greatest health crisis of our times and now working towards averting a cancer crisis
  • Innovation Presentation: Embedded, implanted and digestible sensors – Monitoring the affects of Chemotherapy at home
  • Scientific Research Presentation: Immune based therapy against advanced breast cancers
  • Tech Talk: AI based therapy design- Better plans and more insights in treatment of cancer patients
Session 4Cancer Care Continuum+

Schedule

  • Community Engagement Panel: Partnering to Improve cancer care in under developed MENA regions
  • Impact Story: Cancer Care for refugees & displaced Populations
  • Insight: Implementation & Integration of Telemedicine in Cancer Care Continuum
  • Presentation: Oncology Nursing – Enhancing Evidence based practice to improve care
  • Stakeholders Panel: Cancer Prevention & the importance of a proactive approach
  • Interactive Q & A

Register Now

Fill out my online form.